Ierland - Engels - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - aciclovir - powder for solution for infusion - 250 milligram(s) - nucleosides and nucleotides excl. reverse transcriptase inhibitors; aciclovir

Israël - Engels - Ministry of Health

glaxo smith kline (israel) ltd - aciclovir - powder for solution for infusion - aciclovir 250 mg/vial - aciclovir - aciclovir - zovirax i.v. is indicated for the treatment of herpes simplex infections in immunocompromised patients and severe initial genital herpes in the non-immunocompromised.zovirax i.v. is indicated for the prophylaxis of herpes simplex infections in immunocompromised patients.zovirax i.v. is indicated for the treatment of varicella zoster infections.zovirax i.v. is indicated for the treatment of herpes encephalitis.zovirax i.v. is indicated for the treatment of herpes simplex infections in the neonate and infant up to 3 months of age.

Verenigd Koninkrijk - Engels - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - aciclovir sodium - powder for solution for infusion - 250mg

Verenigd Koninkrijk - Engels - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - aciclovir sodium - powder for solution for infusion - 500mg

Malta - Engels - Medicines Authority

glaxo smithkline ireland limited - aciclovir 250 mg - powder for solution for infusion

Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - aciclovir 250mg (as the freeze -dried sodium salt) - powder for infusion - 250 mg - active: aciclovir 250mg (as the freeze -dried sodium salt) excipient: sodium hydroxide water for injection - zovirax iv for infusion is indicated for the treatment of herpes simplex infections. zovirax iv for infusion is indicated for the prophylaxis of herpes simplex infections in immune compromised patients. zovirax iv for infusion is indicated in the treatment of varicella zoster infections. zovirax iv for infusion is indicated for the treatment of herpes simplex infections in the neonate. zovirax iv for infusion is indicated for prophylaxis of cmv infection in bone marrow transplant recipients. it has been shown that high dose intravenous zovirax reduces the incidence and delays the onset of cmv infection. when high dose intravenous zovirax is followed by 6 months treatment with high dose oral zovirax (see prescribing information for oral zovirax) mortality and the incidence of viraemia are also reduced.

Australië - Engels - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - ganciclovir sodium, quantity: 546 mg (equivalent: ganciclovir, qty 500 mg) - injection, powder for - excipient ingredients: - ganciclovir sxp (ganciclovir) administered as the iv infusion is indicated for the palliative treatment of confirmed sight-threatening cytomegalovirus (cmv) disease in aids and other severely immunocompromised individuals. it is indicated for the treatment of confirmed cmv pneumonitis in bone marrow transplant patients. it is also indicated for the prophylaxis of cmv infection and disease following bone marrow and solid organ transplantation in patients at risk of cmv disease.,note: ganciclovir sxp (ganciclovir) is not indicated for congenital or neonatal cmv disease; nor for the treatment of cmv infection in non-immunocompromised individuals.

Maleisië - Engels - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

glaxosmithkline pharmaceutical sdn. bhd. - acyclovir -

Australië - Engels - Department of Health (Therapeutic Goods Administration)

pharmaco australia ltd - ganciclovir sodium, quantity: 543 mg (equivalent: ganciclovir, qty 500 mg) - injection, powder for - excipient ingredients: - indications as at 12 october 2005: cymevene (ganciclovir) administered as the intravenous infusion is indicated for the palliative treatment of confirmed sight-threatening cytomegalovirus (cmv) disease in aids and other severely immunocompromised individuals. it is indicated for the treatment of confirmed cmv pneumonitis in bone marrow transplant patients. it is also indicated for the prophylaxis of cmv infection and disease following bone marrow and solid organ transplantation in patients at risk of cmv disease. note: cymevene (ganciclovir) is not indicated for congenital or neonatal cmv disease; nor for the treatment of cmv infection in non-immunocompromised individuals.

Israël - Engels - Ministry of Health

glaxo smith kline (israel) ltd - aciclovir - tablets - aciclovir 400 mg - aciclovir - aciclovir - •zovirax tablets are indicated for the treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes (excluding neonatal hsv and severe hsv infections in immunocompromised children).•zovirax tablets are indicated for the suppression (prevention of recurrences) of recurrent herpes simplex infections in immunocompetent patients.•zovirax tablets are indicated for the prophylaxis of herpes simplex infections in immunocompromised patients.•zovirax tablets are indicated for the treatment of varicella (chickenpox) and herpes zoster (shingles) infections